04:30 PM EDT, 08/12/2026 (MT Newswires) -- Ivan Hyep, Chief Financial Officer, on August 10, 2026, sold 12,500 shares in Bicara Therapeutics ( BCAX ) for $349,591. Following the Form 4 filing with the SEC, Hyep has control over a total of 129,855 common shares of the company, with 129,855 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/2023658/000147083126000814/xslF345X05/wk-form4_1786565959.xml